OA08170A - Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues. - Google Patents

Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues.

Info

Publication number
OA08170A
OA08170A OA58722A OA58722A OA08170A OA 08170 A OA08170 A OA 08170A OA 58722 A OA58722 A OA 58722A OA 58722 A OA58722 A OA 58722A OA 08170 A OA08170 A OA 08170A
Authority
OA
OAPI
Prior art keywords
solubilization
pharmaceutical compositions
active principles
aqueous
mucous
Prior art date
Application number
OA58722A
Other languages
English (en)
French (fr)
Original Assignee
Corbiere Jerome
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corbiere Jerome filed Critical Corbiere Jerome
Publication of OA08170A publication Critical patent/OA08170A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Indole Compounds (AREA)
OA58722A 1984-03-14 1985-11-13 Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues. OA08170A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH127984 1984-03-14

Publications (1)

Publication Number Publication Date
OA08170A true OA08170A (fr) 1987-03-31

Family

ID=4206704

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58722A OA08170A (fr) 1984-03-14 1985-11-13 Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues.

Country Status (12)

Country Link
US (1) US4794117A (de)
EP (1) EP0173729B1 (de)
JP (1) JPS61501566A (de)
KR (1) KR930000029B1 (de)
AT (1) ATE57472T1 (de)
AU (1) AU573321B2 (de)
DE (1) DE3580140D1 (de)
HU (1) HU195918B (de)
IT (1) IT1200410B (de)
NO (1) NO165626C (de)
OA (1) OA08170A (de)
WO (1) WO1985004106A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
NO175404C (no) * 1987-09-11 1994-10-12 Syntex Inc Fremgangsmåte for fremstilling av et öyepreparat og konserveringsmiddelsystem for et slikt preparat
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
EP0436726B1 (de) * 1989-08-03 1993-10-20 Eisai Co., Ltd. Verfahren zur photostabilisierung von augenspüllösungen
DE4342907A1 (de) * 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
SK280278B6 (sk) * 1994-09-01 1999-10-08 Pharmacia + Upjohn Company Sterilná vodná farmaceutická kompozícia na parente
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
EP1568369A1 (de) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
EP1942902A1 (de) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Meloxicam enthaltende pharmazeutische zubereitung
WO2009091622A1 (en) * 2008-01-18 2009-07-23 Dow Global Technologies Inc. Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol
CN102300552A (zh) 2009-02-03 2011-12-28 太阳星光齿磨公司 含有桔皮苷的组合物
PL4378443T3 (pl) 2009-10-12 2025-09-08 Boehringer Ingelheim Vetmedica Gmbh Pojemniki na kompozycje zawierające meloksykam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
MX2013000578A (es) * 2010-07-21 2013-02-21 Alcon Res Ltd Composicion farmaceutica con caracteristicas de solubilidad incrementadas.
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916432A1 (de) * 1969-03-31 1970-10-08 Dresden Arzneimittel Verfahren zur Herstellung von Injektionsloesungen von therapeutisch wertvollen Benzodiazepinderivaten und ihren Kombinationen mit anderen Wirkstoffen
IL33774A0 (en) * 1970-01-26 1970-03-22 Abic Ltd A water-soluble composition comprising sulfadimidine and pyrimethamine
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Also Published As

Publication number Publication date
NO165626B (no) 1990-12-03
US4794117A (en) 1988-12-27
NO854461L (no) 1985-11-08
KR930000029B1 (ko) 1993-01-06
HUT38263A (en) 1986-05-28
DE3580140D1 (de) 1990-11-22
AU4064585A (en) 1985-10-11
IT1200410B (it) 1989-01-18
AU573321B2 (en) 1988-06-02
IT8519873A0 (it) 1985-03-13
EP0173729B1 (de) 1990-10-17
EP0173729A1 (de) 1986-03-12
WO1985004106A1 (fr) 1985-09-26
HU195918B (en) 1988-08-29
KR850700216A (ko) 1985-12-26
ATE57472T1 (de) 1990-11-15
NO165626C (no) 1991-03-13
JPS61501566A (ja) 1986-07-31

Similar Documents

Publication Publication Date Title
OA08170A (fr) Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues.
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
ATE119771T1 (de) Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür.
BR0109704A (pt) Método de tratamento usando conjugados de imunógeno ligando
NO891415D0 (no) Fremstilling av substituerte flavonoidforbindelser og salter og farmasoeytiske preparater derav.
ES8602404A1 (es) Metodo de producir complejos solubles en agua de principios activos insolubles en agua y fosfolipidos
FI832355L (fi) 9-(2-hydroxyetoximetyl)guanidin-derivat
PT96400A (pt) Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
DK0388956T3 (da) Phtalinidderivat, farmaceutisk præparat og anvendelse
SE8602743D0 (sv) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
IT8721538A0 (it) Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
RU92004357A (ru) Производные амида n-фенил-2-циано-3-оксикротоновой кислоты и их применение в качестве лекарственных средств с иммуномодуляторным действием
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
KR850001687A (ko) 안정화 항균성 동결 건조제제
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
EA200100214A1 (ru) Применение производных камптотецина с пониженной гастроинтестинальной токсичностью
DE69027256D1 (de) Sulfatiertes polysaccharid, dessen pharmazeutisch verträgliche salze, dessen herstellung und medikament, das dieses als wirksstoff enthält
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
IT1136624B (it) Prodotti di salificazione di acidi colici,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные